logo
Select company
Select metric
$ 27.72MNet Cash Flow - Operations
VS
Market
46
Sector
78
Industry
94
History
87
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ 27.72M
3/31/2025$ 34.67M
12/31/2024$ 42M
9/30/2024$ -57.29M
6/30/2024$ -61M
3/31/2024$ -58.56M
12/31/2023$ -43.8M
9/30/2023$ -97.4M
6/30/2023$ -93.29M
3/31/2023$ -88.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Operations stands at $ -23.05M.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average CF - Operations has been $ -50.36M.
  • The median CF - Operations for MONTE ROSA THERAPEUTICS INC during this period was $ -60.18M
  • MONTE ROSA THERAPEUTICS INC reached its highest CF - Operations over the past 5 years at $ 42M.
  • The lowest CF - Operations recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ -97.4M

MONTE ROSA THERAPEUTICS INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
VNDA : VANDA PHARMACEUTICALS INC $ -64.8MHRTX : HERON THERAPEUTICS INC $ -28.15MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -64.94MCTMX : CYTOMX THERAPEUTICS INC $ -77.43MRGNX : REGENXBIO INC $ -87.89MMGNX : MACROGENICS INC $ -72.12MTRDA : ENTRADA THERAPEUTICS INC $ -123.87MPBYI : PUMA BIOTECHNOLOGY INC $ 44.34MCDXS : CODEXIS INC $ -61.22MSCPH : SCPHARMACEUTICALS INC $ -65.86M

Similar metrics to CF - Operations:

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

GLUE - Net Cash Flow - Operations, Last 5 years

$ -97.4M

Minimum

Sep 30, 2023

$ 42M

Maximum

Dec 31, 2024

$ -50.36M

Average

$ -60.18M

Median

CF - Operations Benchmark Analysis

 The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 57.94M with a standard deviation of $ 141.66M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.27K
min$ -406M
max$ 506.5M
average$ 57.94M
median$ 10.78M
std$ 141.66M